Publicaciones en colaboración con investigadoras/es de Universidad Complutense de Madrid (31)

2024

  1. 3D-printed Laponite/Alginate hydrogel-based suppositories for versatile drug loading and release

    Drug Delivery and Translational Research

2023

  1. Correction to: Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective (Cell & Bioscience, (2023), 13, 1, (44), 10.1186/s13578-023-00986-9)

    Cell and Bioscience

  2. Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective

    Cell and Bioscience, Vol. 13, Núm. 1

2022

  1. Caffeine, D-glucuronolactone and Taurine Content in Energy Drinks: Exposure and Risk Assessment

    Nutrients, Vol. 14, Núm. 23

  2. Inflammation biomarkers in suicide attempts and their relation to abuse, global functioning and cognition

    World Journal of Biological Psychiatry, Vol. 23, Núm. 4, pp. 307-317

  3. Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients

    Frontiers in Immunology, Vol. 13

2021

  1. Food-based dietary guidelines around the world: A comparative analysis to update aesan scientific committee dietary recommendations

    Nutrients, Vol. 13, Núm. 9

  2. Polystyrene Nanopillars with Inbuilt Carbon Nanotubes Enable Synaptic Modulation and Stimulation in Interfaced Neuronal Networks

    Advanced Materials Interfaces, Vol. 8, Núm. 9

2020

  1. Informe del Comité Científico de la Agencia Española de Seguridad Alimentaria y Nutrición (AESAN) de revisión y actualización de las Recomendaciones Dietéticas para la población española

    Revista del Comité Científico de la AESAN, Núm. 32, pp. 11-58

  2. Informe del Comité Científico de la Agencia Española de Seguridad Alimentaria y Nutrición (AESAN) sobre el riesgo asociado al consumo de complementos alimenticios que contienen curcumina como ingrediente

    Revista del Comité Científico de la AESAN, Núm. 32, pp. 85-112

  3. Interfacing Neurons with Nanostructured Electrodes Modulates Synaptic Circuit Features

    Advanced Biosystems, Vol. 4, Núm. 9

2019

  1. Association between medication adherence and oxidative stress in patients with first-episode mania

    Frontiers in Psychiatry, Vol. 10, Núm. MAR

  2. Cohort profile: Design and methods of the PREDIMED-Plus randomized trial

    International Journal of Epidemiology, Vol. 48, Núm. 2, pp. 387-388o

2018

  1. The complex association between the antioxidant defense system and clinical status in early psychosis

    PLoS ONE, Vol. 13, Núm. 4

2017

  1. Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 8, pp. 131-138

2016

  1. BDNF and NGF Signalling in Early Phases of Psychosis: Relationship with Inflammation and Response to Antipsychotics after 1 Year

    Schizophrenia Bulletin, Vol. 42, Núm. 1, pp. 142-151

2015

  1. Análisis farmacocinético-farmacodinámico en microbiología: Herramienta para evaluar el tratamiento antimicrobiano

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 1, pp. 48-57

2014

  1. Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study

    Schizophrenia Research, Vol. 156, Núm. 1, pp. 23-29

  2. In vitro analysis of femtosecond laser as an alternative to acid etching for achieving suitable bond strength of brackets to human enamel

    Lasers in Medical Science, Vol. 29, Núm. 3, pp. 897-905

2012

  1. Antioxidant defense system and family environment in adolescents with family history of psychosis

    BMC Psychiatry, Vol. 12